| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Agennix is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Houston, TX. To find more information about Agennix, please visit www.agennix.com
NeoPath Health is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
More than 65 academic medical centers use ARUP as their primary reference laboratory and ARUP also provides all laboratory services, including phlebotomy and support services, for the 490-bed University of Utah Hospitals and Clinics. ARUP's 1,700
Ample Scientific is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.